4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000075
Chief Executive Officer sold 8,321 shares at $14.89 ($123,900)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salzmann Peter Chief Executive Officer | 2025-04-16 | Sale | −8,321 | $14.89 | $123,900 | 1,178,191 | D |
| Open-market sales · 8,321 sh · avg $14.89 · $123,900 | |||||||
Loading xslF345X05/wk-form4_1744920441.xml…